Accord’s manufacturing arm, Intas pharmaceuticals, comprises the main manufacturing and operations sites of the Intas Group.

The group operates 2 significant EU cGMP approved manufacturing sites, SEZ and Matoda located in Ahmedabad in North West India. Oral solid dose capabilities include anti-cancer and immunosuppressant drugs, as well as conventional tablets and capsules and effervescent and pellet formulations.

Parenteral capabilities include regular and cytotoxic solution and lyophilised vials as well as regular and controlled drug ampoules.